At CROI 2025, researchers from Université de Montréal discuss how fostemsavir could target residual viral fragments and reduce inflammation.
Mehdi Benlarbi
Advertisement
PhD Student at Univsersité de Montréal.
Articles by Mehdi Benlarbi
Advertisement
Latest Updated Articles
Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIVPublished: March 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Refuses to Review Moderna's Influenza Vaccine for Potential Approval
2
Friend of Court Filing Supports AAP Lawsuit against HHS Vaccine Policy Changes
3
Obesity Linked to One in Ten Global Infectious Disease Deaths, Large Study Finds
4
Top Infectious Disease News Stories Week of February 1 - February 7
5